Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.

Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.

Chemokine (C-C motif) ligand 2 (CCL2), commonly known as monocyte chemoattractant protein-1 (MCP-1), has been implicated in the pathogenesis of many diseases characterized by monocytic infiltration. However, limited data have been reported on MCP-1 in type 1 diabetes (T1D) and the findings are incon...

Full description

Bibliographic Details
Main Authors:	Ruili Guan, Sharad Purohit, Hongjie Wang, Bruce Bode, John Chip Reed, R Dennis Steed, Stephen W Anderson, Leigh Steed, Diane Hopkins, Chun Xia, Jin-Xiong She
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-04-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3075244?pdf=render

Similar Items

Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria
by: Sharad Purohit, et al.
Published: (2018-01-01)

Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes
by: Shruti Sharma, et al.
Published: (2015-01-01)

Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
by: Isabella Viana Gomes Schettini, et al.
Published: (2021-07-01)

The Role of Chemokine (C‐C Motif) Ligand 7 (CCL7) in Hepatocellular Carcinoma: Expression, Function, and Mechanisms
by: Yangkun Luo, et al.
Published: (2025-03-01)

Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk.
by: Hongjie Wang, et al.
Published: (2010-07-01)

C–C motif chemokine ligand 2/C–C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
by: Xiangzi Wang, et al.
Published: (2025-08-01)

Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies.
by: Tomomitsu Hirota, et al.
Published: (2011-01-01)

Breast Cancer: Coordinated Regulation of CCL2 Secretion by Intracellular Glycosaminoglycans and Chemokine Motifs
by: Yaeli Lebel-Haziv, et al.
Published: (2014-09-01)

Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
by: Mei-Lin Su, et al.
Published: (2014-01-01)

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
by: Sean M. Bagshaw, et al.
Published: (2021-05-01)

Pan-cancer characterization of C–C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target
by: Wenming Zhao, et al.
Published: (2025-03-01)

Adipose-specific C-C motif chemokine ligand (CCL) 19 overexpression drives the mice to both insulin resistance and weight gain
by: Yuki Nishimura, et al.
Published: (2021-03-01)

C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
by: Zhiwen Fan, et al.
Published: (2023-09-01)

The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway
by: Paul MH. Tran, et al.
Published: (2021-01-01)

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility
by: Jing Zhou, et al.
Published: (2021-01-01)

The Critical Role of Chemokine (C–C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis
by: Debby Reuveni, et al.
Published: (2018-08-01)

Serum C‐X‐C motif chemokine ligand 14 levels are associated with serum C‐peptide and fatty liver index in type 2 diabetes mellitus patients
by: Yuriko Matsushita, et al.
Published: (2021-06-01)

CCL2/C–C chemokine receptor type 2‐mediated interactions among mast cells, basophils, and endothelial cells
by: Maruša Rihar, et al.
Published: (2025-02-01)

Investigating chemokine-matrix networks in breast cancer: tenascin-C sets the tone for CCL2
by: Gschwandtner, M, et al.
Published: (2023)

Isolation and Characterization of C-C Chemokine Ligand 7 (CCL7) in Cynomolgus Macaques
by: Sela S. Mariya, et al.
Published: (2019-12-01)

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)
by: Echeverri J, et al.
Published: (2024-01-01)

Chemerin attracts neutrophil reverse migration by interacting with C–C motif chemokine receptor-like 2
by: Jingjing Ji, et al.
Published: (2024-06-01)

Effects of chemokine (C-C motif) receptor 2 and 3 antagonists in rat models of hemorrhagic shock.
by: McWayne Weche, et al.
Published: (2023-01-01)

Chemokine (C–C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children
by: Yanjie Shen, et al.
Published: (2022-06-01)

CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01)

IGF-binding proteins in type 1 diabetes are more severely altered in the presence of complications
by: Ashok eSharma, et al.
Published: (2016-01-01)

The C-X-C Motif Chemokine Ligand 5, Which Exerts an Antioxidant Role by Inducing HO-1 Expression, Is C-X-C Motif Chemokine Receptor 2-Dependent in Human Prostate Stroma and Cancer Cells
by: Kang-Shuo Chang, et al.
Published: (2024-12-01)

Multifaceted impact of host C-C chemokine CCL2 in the immuno-pathogensis of HIV-1/ M tuberculosis co-infection
by: A Wahid Ansari, et al.
Published: (2013-10-01)

Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain
by: Knut eBiber, et al.
Published: (2014-08-01)

Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response.
by: Stephen Wood, et al.
Published: (2014-01-01)

Interaction between epidermal growth factor receptor and C-C motif chemokine receptor 2 in the ovulatory cascade
by: J. G. Conte, et al.
Published: (2023-04-01)

The Intricate Expression of CC Chemokines in Glial Tumors: Evidence for Involvement of CCL2 and CCL5 but Not CCL11
by: Mozhgan Moogooei, et al.
Published: (2015-12-01)

Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)/chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells.
by: Xiuling Li, et al.
Published: (2013-01-01)

The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2)
by: Lisi Simonetta, et al.
Published: (2009-12-01)

A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation
by: Ting-Ting Chang, et al.
Published: (2021-04-01)

Epicatechin suppresses the expression of C-C motif chemokine ligand 19 and ameliorates periodontitis
by: Tomomi Sano, et al.
Published: (2024-11-01)

Expression of C–C motif chemokines and their receptors in bovine placentomes at spontaneous and induced parturition
by: Hiroki HIRAYAMA, et al.
Published: (2019-11-01)

The Roles of C-X-C Motif Chemokine Ligand 10 (CXCL10) in Dengue
by: Siti Noraihan Khamis, et al.
Published: (2022-09-01)

Blockage of C-X-C Motif Chemokine Receptor 2 (CXCR2) Suppressed Uric Acid (UA)-Induced Cardiac Remodeling
by: Mingxi Xu, et al.
Published: (2021-07-01)

A review on the variable copies of C-C motif chemokine ligand 3 like 1 (CCL3L1) gene among different populations and current methods for quantification
by: Jamaluddin, Jalilah, et al.
Published: (2019)